MeSH Browser

MeSH Supplementary: cilgavimab and tixagevimab drug combination
Unique ID: C000714168
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C000714168
Entry Term(s): AZD 7442; AZD-7442; AZD1061 and AZD8895; AZD7442; Evusheld; cilgavimab and tixagevimab antibody combination; cilgavimab and tixagevimab mixture; cilgavimab, tixagevimab drug combination; tixagevimab and cilgavimab antibody combination; tixagevimab and cilgavimab drug combination; tixagevimab and cilgavimab mixture
Pharm Action: Antiviral Agents
Registry Numbers: 0
Heading Mapped to: *Antibodies, Monoclonal; Drug Combinations; *Antibodies, Neutralizing
Frequency: 15
Note: a mixture of two SARS-CoV-2 neutralizing antibodies
Date of Entry: 2021/03/01
Revision Date: 2021/12/09

Concept UI: M000744511
Terms: AZD7442 Preferred Term
Term UI T001099418
Date03/01/2021
LexicalTag LAB
ThesaurusID NLM (2021); AZD 7442
Term UI T001099419
Date03/01/2021
LexicalTag LAB
ThesaurusID NLM (2021); AZD-7442
Term UI T001099420
Date03/01/2021
LexicalTag LAB
ThesaurusID NLM (2021); AZD1061 and AZD8895
Term UI T001099421
Date03/01/2021
LexicalTag LAB
ThesaurusID NLM (2021)

cilgavimab and tixagevimab drug combination MeSH Supplementary Concept Data 2025